Lixte Biotechnology Holdings, Inc. Share Price
LIXTLixte Biotechnology Holdings, Inc. Stock Performance
Open $3.14 | Prev. Close $3.14 | Circuit Range N/A |
Day Range $2.98 - $3.14 | Year Range $0.64 - $6.14 | Volume 1,570 |
Average Traded $3.02 |
Lixte Biotechnology Holdings, Inc. Share Price Chart
About Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Lixte Biotechnology Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Feb-26 | $3.14 | $3.02 | +0.00% |
05-Feb-26 | $3.14 | $3.02 | -6.50% |
04-Feb-26 | $3.11 | $3.23 | -6.10% |
03-Feb-26 | $3.14 | $3.44 | -4.18% |
02-Feb-26 | $3.60 | $3.59 | -5.03% |
30-Jan-26 | $3.88 | $3.78 | -4.79% |
29-Jan-26 | $3.84 | $3.97 | +6.72% |
FAQs on Lixte Biotechnology Holdings, Inc. Share Price
Can I buy Lixte Biotechnology Holdings, Inc. shares in India?
What is the share price of Lixte Biotechnology Holdings, Inc.?
What is the 5 year returns of Lixte Biotechnology Holdings, Inc.?
What are the high & low stock price of Lixte Biotechnology Holdings, Inc. today?
What is the 52-week high and low of Lixte Biotechnology Holdings, Inc. stock?